ERGOMETRIN Lek 0.2 mg film-coated tablet

Similar documents
REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution

Dulcolax 5 mg, film-coated tablets

FLUIMUKAN PLUS 600 mg effervescent tablets

SPASMEX FORTE 5mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

Motens 2 mg and 4 mg Tablets lacidipine

OSPEN 1000; OSPEN ,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

NORVASC 5 mg and 10 mg tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

FLUIMUKAN AKUT 600 mg effervescent tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

METHYLDOPA 250 mg Film-coated Tablets

TAFEN NASAL 50mcg nasal spray, suspension

BERLITHION 600 mg Capsule, soft

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

AVIOMARIN 50 mg tablets

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Neuro-Medivitan is a vitamin preparation. Intended use Systemic neurological disorders due to proven deficiency of vitamins B1 and B6.

Coldrex MaxGrip Lemon Powder for oral solution

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

1. What Betahistine dihydrochloride tablets is and what it is used for

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER

TREANA 5mg and 10mg Film-coated Tablets

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

What is in this leaflet

Irbenida H 150mg/12,5mg film-coated tablets

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

ATORIS 10, 20, 40 mg film-coated tablets

2 What you need to know before you take Naramig

PACKAGE LEAFLET: INFORMATION FOR THE USER. RIBOKSĪNS 200 mg film- coated tablets Inosinum

Package leaflet: Information for the patient

PROSCAR 5mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT PROSCAR IS AND WHAT IS IT USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PACKAGE LEAFLET: INFORMATION FOR USER ROPINIROLE 2 mg FILM-COATED TABLETS. Ropinirole

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

LIPOFEN SR 250 mg CAPSULE, HARD

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

SIOFOR mg film-coated tablets

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

HERNOVIR 200 mg tablets

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

SINGULAIR JUNIOR 5mg chewable tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

FAVISTAN 20 mg, tablets

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

a condition called secondary hyperparathyroidism (high-per-pear-a-thigh-royd-izm) in adults with kidney disease who require dialysis treatment.

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

XYZAL 5 MG FILM-COATED TABLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zolmitriptan Teva 5 mg film-coated tablets. Zolmitriptan

PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 10 mg film-coated tablets Montelukast

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: information for the user. Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets Sildenafil

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the user. Cinfalair10 mg film-coated tablets montelukast

PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS. Please read this leaflet carefully before you start taking FEDALOC tablets.

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the patient

Flavamed Forte 30 mg/5 ml, oral solution

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the user. ARICEPT 10 mg Film Coated Tablets (Donepezil Hydrochloride)

URSOSAN 250mg capsule, hard

PLAVIX 75mg film-coated tablets

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER ERGOMETRIN Lek 0.2 mg film-coated tablet ERGOMETRINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines the conditions under which the medicine should be used and information on its known safety The product information may be updated several times within its shelf life, and there could be differences between the version of information shown here and other information in the public domain or in the package insert This leaflet may not contain all the information about the medicine or the information may not be the most up to date version for this product If you have any questions or are not sure about anything, ask your doctor or pharmacist Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only Do not pass it on to others It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist This includes any possible side effects not listed in this leaflet What is in this leaflet? 1.What ERGOMETRIN Lek is and what it is used for 2.Before you take ERGOMETRIN Lek 3.How to take ERGOMETRIN Lek 4.Possible side effects 5.How to store ERGOMETRIN Lek 6.Further information 1. WHAT ERGOMETRIN LEK IS AND WHAT IT IS USED FOR Ergometrin Lek 0.2 mg film-coated tablets lead to muscle contractions of the uterus. Ergometrine is water soluble alkaloid that is found naturally in ergot (Secale cornutum, rye fungus). It stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and increases the tone of the muscles of the uterus. Its effect is especially strong during pregnancy and postpartum period. ERGOMETRIN Lek film-coated tablets are used: for the prevention and treatment of bleeding from the uterus after childbirth, Caesarean or abortion (miscarriage) to facilitate reduction of the uterus to its normal size after childbirth, when the tone of muscles is decreased Medicine begins to Act 5-15 minutes after application.

2. BEFORE YOU TAKE ERGOMETRIN LEK Do not use ERGOMETRIN Lek: If you are allergic (hypersensitive) to ergometrine, ergot alkaloids (alkaloid group of fungus) or any of the other ingredients of ERGOMETRIN Lek If you are pregnant or think you may be pregnant If there is a risk of miscarriage If you are pregnant and you are having problems with swelling, increased blood pressure and protein in the urine (EPH gestosis), or even convulsions (eclampsia) If you are in the first or second stage of labor If you have sepsis (blood poisoning, the presence of bacteria or other infectious organisms or their toxins in the blood or tissues) If you are breast-feeding If you have Vascular disease of limbs (an advanced disease of peripheral vessels such as progressive obliterative angiopathy) If you are having problems with lungs, liver or kidney problems If you currently treat severe heart disease If you have heart problems due to lack of blood flow to the heart muscle (history of pain in the chest or heart attack) If you have had seizures due to transient problems of blood circulation in the brain (transient ischemic attacks) or stroke If you have severe injury of cardiac mitral valve (severe mitral stenosis) If you are taking medicines that constrict blood vessels (such as adrenaline, dopamine, propranolol) If you are taking antiviral medicines (such as saquinavir) If you are taking systemic antifungals (antifungal medicines, such as ketoconazole) If you are taking antidepressants (such as fluoxetine) If you are taking antimicrobial medicines (such as macrolides, tetracyclines, metronidazole) If you are taking Leukotriene Receptor Antagonists (such as zileuton, medicine to treat asthma) Take special care with ERGOMETRIN Lek: If you have high blood pressure If you have Porphyria (a disorder of metabolism of proteins) Anesthesia should be avoided. Do not smoke while taking ERGOMETRIN Lek. Effects of ERGOMETRIN Lek are reduced if you have hypocalcaemia (low calcium levels). With multiple childbirth, you shouldn't take ERGOMETRIN Lek until after the birth of the last child. Do not take ERGOMETRIN Lek longer than 7 days. Taking other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicine. This includes medicines that can be purchased without a prescription. concomitant use with halothane (a general anesthetic) reduces the effects to uterus Ergometrin Lek you should wait at least 24 hours after discontinuation of the use of Ergometrine to use triptane for the treatment of migraine headache (sumatriptan, zolmitriptan). If you are taking triptane, you must wait at least 6 hours prior to the application of ERGOMETRIN Lek. ERGOMETRIN Lek increases the effects of prostaglandins (medicines that stimulate uterine contraction).

Taking ERGOMETRIN Lek with food and drink Grapefruit juice may increase the plasma concentrations of ergometrine; do not drink it while taking this medicine. Pregnancy and breastfeeding Ask your doctor or pharmacist for advice before using any medicine. Pregnancy If you are pregnant, think you are pregnant or planning a pregnancy, be sure to tell the doctor before starting the treatment. The medicine should not be used in pregnant women. Breast feeding Tell your doctor if you are breast-feeding. Ergometrine passes into breast milk and may cause signs of poisoning (Ergotism) in infants. Therefore, nursing mothers should not take this medicine. Driving and using machines In some patients, the medicine can cause dizziness, which temporarily reduces the ability to drive and use machines. Important information about some of the ingredients of ERGOMETRIN Lek ERGOMETRIN Lek coated tablets contain lactose. If a doctor told you that you have intolerance to some sugars, contact him before taking this medicine. 3. HOW TO TAKE ERGOMETRIN LEK Your doctor will decide how many tablets a day you need to take, and how long will your treatment last. You should exactly follow the doctor s instructions. You should not change the dose or stop treatment without consulting your doctor. For the treatment of incomplete shrinking of the uterus after childbirth and slight bleeding, take 1-2 tablets every 6 to 12 hours, but not more than 8 tablets per day. Do not take the medicine longer than 7 days. If you have the impression that the effect of Ergometrin Lek's is too strong or too weak, contact your doctor or pharmacist. If you take more ERGOMETRIN Lek than you should If you take too many tablets, contact your doctor. Bring any remaining tablets with you to show them to the doctor. Signs of acute poisoning can occur within 5 minutes after taking the medicine. They include nausea, vomiting, diarrhea and painful contractions of the uterus. The main symptoms of overdose are cramps and problems with blood circulation in extremities. Other symptoms are reduced or raised blood pressure, weak pulse, shortness of breath, loss of consciousness, cold extremities, chest pain, and increased coagulation of the blood. Chronic intoxication (Ergotism) may occur due to long-term administration of ERGOMETRIN Lek, medicine overdose or hypersensitivity to the medicine. The signs are the same as with acute intoxication; symptomatic treatment is required. If you forget to take ERGOMETRIN Lek If you miss a dose, take the next dose at the usual time and continue to take the medicine as instructed by a doctor. Do not take a double dose to make up for a forgotten dose

If you have further questions about taking this medicine, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like any other medicine, ERGOMETRIN Lek may cause side effects, although not everybody gets them. Assessment of side effects is based on the following frequencies: Very common: affects more than 1 in 10 patients Common: affects about 1 to 10 in 100 patients Uncommon: occurs in 1 to 10 in 1000 patients Rare: affects about 1 to 10 in 10000 patients Very rare: affects less than 1 in 10000 patients Unknown: frequency cannot be estimated on the basis of the available data You may experience the following side effects: Common nausea and vomiting headache high blood pressure Very rare decreased cardiac operation problem with heartbeats and other heart rhythm problems pain in the chest heart attack vertigo stroke ringing in the ears (Tinnitus) difficulty in breathing or shortness of breath abdominal pain diarrhea severe allergic reaction that causes difficulty in breathing or dizziness with possible additional difficulties (skin rash, hypotension, anaphylactic shock) confusion If any of the side effects get worse or you notice side effects not mentioned in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE ERGOMETRIN LEK Keep the medicine out of reach and sight of children. Keep at temperature below 25 C, protected from light and moisture. Shelf life: 3 years Do not use ERGOMETRIN Lek after the expiry date stated on the box. The expiry date of the medicine refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What ERGOMETRIN Lek contains The active substance is ergometrine.

Each tablet contains 0.2 mg of ergometrine maleate. The other ingredients are: Core: butylated hydroxyanisole (E 320) lactose monohydrate povidone crospovidone corn starch maleate acid Stearic acid Talc Coating: carnauba wax hypromellose macrogol 400 iron oxide, Brown (E172) What ERGOMETRIN Lek looks like and contents of the pack Film-coated tablets. Dark Brown, round, biconvex, film-coated tablets. Boxes with brown glass bottles of 20 film-coated tablets, every Tablet contains 0.2 mg of ergometrine maleate; adsorption capsules in each bottle. Regime of dispensing The medicine is issued to the doctor's prescription Manufacturer LEK farmacevtska družba d.d., Verovškova 57, Ljubljana, Republic of Slovenia Manufacturer of the medicinal product LEK farmacevtska družba d.d., Verovškova 57, Ljubljana, Republic of Slovenia